Social Media Influencers Driving Unofficial Trade for Unlicensed Slimming Medication
An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Drug Acquiring Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are urged to contact these accounts directly for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of rapid British shipping. Vendors promote the substance there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could result in individuals injecting products of unknown origin.
Some professionals said the demand for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Marketing retatrutide on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.
Several content creators try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, advertising, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic material and banned related keywords and query recommendations. The organization stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.
Digital Marketplace Operations
Research also found groups with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with photos of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within moments of entering one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, medical conditions or previous experience.
Item Information and Costs
Within these communities, posts display black plastic parcels with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Service Moderation and Safety Measures
A representative for Telegram said it actively monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they can’t verify. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service connected the increase in interest to current price rises for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has previously encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly significant medical dangers”.
